5-96397408-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000439.5(PCSK1):​c.1650T>C​(p.Asn550Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.37 in 1,610,164 control chromosomes in the GnomAD database, including 112,577 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.38 ( 11019 hom., cov: 32)
Exomes 𝑓: 0.37 ( 101558 hom. )

Consequence

PCSK1
NM_000439.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.23

Publications

25 publications found
Variant links:
Genes affected
PCSK1 (HGNC:8743): (proprotein convertase subtilisin/kexin type 1) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an initial autocatalytic processing event in the ER to generate a heterodimer which exits the ER and sorts to subcellular compartments where a second autocatalytic even takes place and the catalytic activity is acquired. The protease is packaged into and activated in dense core secretory granules and expressed in the neuroendocrine system and brain. This gene encodes one of the seven basic amino acid-specific members which cleave their substrates at single or paired basic residues. It functions in the proteolytic activation of polypeptide hormones and neuropeptides precursors. Mutations in this gene have been associated with susceptibility to obesity and proprotein convertase 1/3 deficiency. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene [provided by RefSeq, Jan 2014]
CAST (HGNC:1515): (calpastatin) The protein encoded by this gene is an endogenous calpain (calcium-dependent cysteine protease) inhibitor. It consists of an N-terminal domain L and four repetitive calpain-inhibition domains (domains 1-4), and it is involved in the proteolysis of amyloid precursor protein. The calpain/calpastatin system is involved in numerous membrane fusion events, such as neural vesicle exocytosis and platelet and red-cell aggregation. The encoded protein is also thought to affect the expression levels of genes encoding structural or regulatory proteins. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jun 2010]
CAST Gene-Disease associations (from GenCC):
  • peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 5-96397408-A-G is Benign according to our data. Variant chr5-96397408-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 354643.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.23 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.437 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCSK1NM_000439.5 linkc.1650T>C p.Asn550Asn synonymous_variant Exon 12 of 14 ENST00000311106.8 NP_000430.3 P29120-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCSK1ENST00000311106.8 linkc.1650T>C p.Asn550Asn synonymous_variant Exon 12 of 14 1 NM_000439.5 ENSP00000308024.2 P29120-1

Frequencies

GnomAD3 genomes
AF:
0.376
AC:
57070
AN:
151892
Hom.:
11014
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.418
Gnomad AMI
AF:
0.362
Gnomad AMR
AF:
0.447
Gnomad ASJ
AF:
0.409
Gnomad EAS
AF:
0.274
Gnomad SAS
AF:
0.283
Gnomad FIN
AF:
0.216
Gnomad MID
AF:
0.380
Gnomad NFE
AF:
0.371
Gnomad OTH
AF:
0.397
GnomAD2 exomes
AF:
0.358
AC:
89902
AN:
251166
AF XY:
0.352
show subpopulations
Gnomad AFR exome
AF:
0.417
Gnomad AMR exome
AF:
0.468
Gnomad ASJ exome
AF:
0.426
Gnomad EAS exome
AF:
0.268
Gnomad FIN exome
AF:
0.218
Gnomad NFE exome
AF:
0.368
Gnomad OTH exome
AF:
0.365
GnomAD4 exome
AF:
0.370
AC:
538956
AN:
1458154
Hom.:
101558
Cov.:
30
AF XY:
0.368
AC XY:
266682
AN XY:
725638
show subpopulations
African (AFR)
AF:
0.419
AC:
14009
AN:
33398
American (AMR)
AF:
0.458
AC:
20487
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.413
AC:
10771
AN:
26102
East Asian (EAS)
AF:
0.299
AC:
11845
AN:
39650
South Asian (SAS)
AF:
0.297
AC:
25617
AN:
86176
European-Finnish (FIN)
AF:
0.225
AC:
12040
AN:
53404
Middle Eastern (MID)
AF:
0.425
AC:
2449
AN:
5760
European-Non Finnish (NFE)
AF:
0.378
AC:
419370
AN:
1108686
Other (OTH)
AF:
0.371
AC:
22368
AN:
60262
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
15767
31534
47300
63067
78834
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13252
26504
39756
53008
66260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.376
AC:
57101
AN:
152010
Hom.:
11019
Cov.:
32
AF XY:
0.371
AC XY:
27570
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.417
AC:
17282
AN:
41434
American (AMR)
AF:
0.446
AC:
6811
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.409
AC:
1419
AN:
3466
East Asian (EAS)
AF:
0.275
AC:
1423
AN:
5176
South Asian (SAS)
AF:
0.282
AC:
1360
AN:
4816
European-Finnish (FIN)
AF:
0.216
AC:
2289
AN:
10582
Middle Eastern (MID)
AF:
0.371
AC:
109
AN:
294
European-Non Finnish (NFE)
AF:
0.371
AC:
25230
AN:
67942
Other (OTH)
AF:
0.401
AC:
848
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1845
3689
5534
7378
9223
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
558
1116
1674
2232
2790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.388
Hom.:
19441
Bravo
AF:
0.395
Asia WGS
AF:
0.280
AC:
978
AN:
3476
EpiCase
AF:
0.383
EpiControl
AF:
0.379

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Obesity due to prohormone convertase I deficiency Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Monogenic Non-Syndromic Obesity Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
3.7
DANN
Benign
0.73
PhyloP100
1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6233; hg19: chr5-95733112; COSMIC: COSV60734130; API